Literature DB >> 32556327

Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children: Multicenter Surveillance, United States, January-March 2020.

Brian Rha1, Joana Y Lively1,2, Janet A Englund3, Mary A Staat4, Geoffrey A Weinberg5, Rangaraj Selvarangan6, Natasha B Halasa7, John V Williams8, Julie A Boom9,10, Leila C Sahni9,10, Marian G Michaels8, Laura S Stewart7, Christopher J Harrison6, Peter G Szilagyi11, Monica M McNeal4, Eileen J Klein3, Bonnie Strelitz3, Kirsten Lacombe3, Elizabeth Schlaudecker4, Mary E Moffatt6, Jennifer E Schuster6, Barbara A Pahud6, Gina Weddle6, Robert W Hickey8, Vasanthi Avadhanula12, Mary E Wikswo1, Aron J Hall1, Aaron T Curns1, Susan I Gerber1, Gayle Langley1.   

Abstract

Previous reports of coronavirus disease 2019 among children in the United States have been based on health jurisdiction reporting. We performed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing on children enrolled in active, prospective, multicenter surveillance during January-March 2020. Among 3187 children, only 4 (0.1%) SARS-CoV-2-positive cases were identified March 20-31 despite evidence of rising community circulation. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society 2020.

Entities:  

Keywords:  COVID-19; acute respiratory illness; pediatrics; public health surveillance

Mesh:

Year:  2020        PMID: 32556327      PMCID: PMC7337823          DOI: 10.1093/jpids/piaa075

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN: 2048-7193            Impact factor:   3.164


  6 in total

1.  Pediatric SARS-CoV-2 seroprevalence during mitigation procedures in Southwestern Pennsylvania.

Authors:  Glenn J Rapsinski; Megan Culler Freeman; Ghady Haidar; Steven H Belle; Joanne H Hasskamp; Sarah E Wheeler
Journal:  J Clin Virol Plus       Date:  2021-06-09

2.  Systematic Testing for Influenza and Coronavirus Disease 2019 Among Patients With Respiratory Illness.

Authors:  Brendan Flannery; Jennifer K Meece; John V Williams; Emily T Martin; Manjusha Gaglani; Michael L Jackson; H Keipp Talbot
Journal:  Clin Infect Dis       Date:  2021-05-04       Impact factor: 9.079

3.  Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses - New Vaccine Surveillance Network, United States, 2016-2021.

Authors:  Ariana Perez; Joana Y Lively; Aaron Curns; Geoffrey A Weinberg; Natasha B Halasa; Mary Allen Staat; Peter G Szilagyi; Laura S Stewart; Monica M McNeal; Benjamin Clopper; Yingtao Zhou; Brett L Whitaker; Elizabeth LeMasters; Elizabeth Harker; Janet A Englund; Eileen J Klein; Rangaraj Selvarangan; Christopher J Harrison; Julie A Boom; Leila C Sahni; Marian G Michaels; John V Williams; Gayle E Langley; Susan I Gerber; Angela Campbell; Aron J Hall; Brian Rha; Meredith McMorrow
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2022-10-07       Impact factor: 35.301

4.  Missing science: A scoping study of COVID-19 epidemiological data in the United States.

Authors:  Rajiv Bhatia; Isabella Sledge; Stefan Baral
Journal:  PLoS One       Date:  2022-10-12       Impact factor: 3.752

5.  Children's role in the COVID-19 pandemic: a systematic review of early surveillance data on susceptibility, severity, and transmissibility.

Authors:  Katy A M Gaythorpe; Sangeeta Bhatia; Tara Mangal; H Juliette T Unwin; Natsuko Imai; Gina Cuomo-Dannenburg; Caroline E Walters; Elita Jauneikaite; Helena Bayley; Mara D Kont; Andria Mousa; Lilith K Whittles; Steven Riley; Neil M Ferguson
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

6.  Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak.

Authors:  Adam S Dingens; Katharine H D Crawford; Amanda Adler; Sarah L Steele; Kirsten Lacombe; Rachel Eguia; Fatima Amanat; Alexandra C Walls; Caitlin R Wolf; Michael Murphy; Deleah Pettie; Lauren Carter; Xuan Qin; Neil P King; David Veesler; Florian Krammer; Jane A Dickerson; Helen Y Chu; Janet A Englund; Jesse D Bloom
Journal:  Nat Commun       Date:  2020-09-01       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.